Preventing bloodstream infection in IV therapy

Area of Science:

• Infection Control
• Patient Safety
• Vascular Access Management

Background:

• Healthcare-associated infections (HAI) represent a significant source of preventable patient harm, posing clinical, political, and economic challenges.
• Vascular access devices are frequently used in hospital and home healthcare settings, making safe management essential.
• Invasive vascular access procedures carry inherent risks, including infiltration, extravasation, phlebitis, and pain.

Purpose of the Study:

• To examine the relationship between intravenous (IV) therapy and bloodstream infections.
• To outline key principles and measures for preventing healthcare-associated infections linked to IV therapy.
• To address the prevention of catheter-related bloodstream infections and central-line associated bloodstream infections.

Main Methods:

• Literature review focusing on the interrelationship between IV therapy and infection prevention.
• Synthesis of current knowledge on preventing healthcare-associated infections in vascular access.
• Summary of essential principles for safe IV therapy and HAI prevention.

Main Results:

• Vascular access procedures are inherently invasive and associated with infection risks.
• Intravenous therapy is a significant pathway for healthcare-associated infections, including bloodstream infections.
• Effective prevention strategies are vital for reducing HAI related to vascular access.

Conclusions:

• Safe vascular access management is a critical component of patient safety and HAI prevention.
• Understanding and implementing measures to prevent IV therapy-associated bloodstream infections are paramount.
• Continuous efforts and adherence to key principles are necessary to minimize HAI in patients requiring vascular access.